NCT07509177

Brief Summary

Do you have Epilepsy? Would you like to participate in a study using PhotoBioModulation (PBM)? PBM is being researched for potential benefits in resolving many stress-related brain disorders. It is a non-invasive technique that delivers light energy to cells and tissues that can promote brain stabilization and self-regulation, cell repair, reduce oxidative stress, and enhance cellular function. We ask you to participate for about 3-4 months and come to our facility for 30 minute sessions 3x a week for 15 weeks. You will receive extensive metabolic testing and an Õura ring for your participation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Aug 2025Aug 2027

Study Start

First participant enrolled

August 11, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 3, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2027

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

March 25, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

EpilepsyStressPhotobiomodulationMetabolic TestingPBM

Outcome Measures

Primary Outcomes (1)

  • Subjective level of stress

    This study will look at how perceived stress can be moderated with 45 20-minute photobiomodulation sessions and how this affects seizure duration, intensity, and frequency in people with epilepsy, with the Perceived Stress Scale (PSS), and a post score 20% improved from the pre-test score.

    Start to post-intervention to 6-month follow-up

Study Arms (2)

Active photobiomodulation sessions

ACTIVE COMPARATOR

Participants will undergo 45 20-minute sessions of photobiomodulation. All other aspects of the study will be the same as the sham group. The Vielight Pro 2 PBM system we'll be using for this study emits pulsed 810nm near infra-red light through the nasal passage and cranium. It is a helmet that is placed on the head, and a light emitter is clipped onto the nostril. The participant will sit comfortably in a dimly-lit room, allow the helmet to be placed on their head and clip to be placed on the nostril (see below). The sessions last 20 minutes. They can read, listen to music, write, or draw during the session.

Other: Photobiomodulation

Control photobiomodulation sessions

SHAM COMPARATOR

One third of the participants will undergo 45 20-minute 'fake' photobiomodulation sessions. All other aspects of the study will be the same as the active group.

Other: Photobiomodulation

Interventions

Transcranial photobiomodulation emits low light (infrared) through the scalp and energizes mitochondria, which in turn produce more energy. It is assumed that many brain-related disorders are afflicted with this phenomenon.

Also known as: Low light therapy
Active photobiomodulation sessionsControl photobiomodulation sessions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 YO
  • Epilepsy - medical diagnosis with at least one seizure within the past 6 months: diagnosis to be obtained from medical records from the treating physician by signature of HIPAA-compliant medical release form
  • Agreement to maintain or reduce medication regimen (based upon prescribers' advice)
  • Available for intake, baseline, post-treatment, 6-month follow-up assessments, and 45 sessions of PBM
  • Willingness to wear an Õura ring at all times (except for charging) for the duration of the study.

You may not qualify if:

  • \< 17 YO
  • Substance use
  • Personality disorders
  • Heavy metal toxicity
  • Mold toxicity
  • Metabolic measures thresholded based on participant type
  • Increase in current medication (dosage and/or type)
  • No new medications prescribed (reduction as prescribed by prescribing physician OK)
  • Current brain bleed
  • Acute TBI within the last 12 months
  • History of neuromodulation, including ECT
  • Brain implants/pumps/shunts
  • History of brain surgery
  • Hormone replacement therapy for menopause or gender transition
  • Untreated sleep disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Brain Health Center Miami

North Miami, Florida, 33162, United States

RECRUITING

Right Mind Wellness Center

Cincinnati, Ohio, 45227, United States

RECRUITING

Holly Maggiano, MD

Warren, Ohio, 44484, United States

RECRUITING

Houston Neuroscience Brain Center

Houston, Texas, 77098, United States

RECRUITING

MeSH Terms

Conditions

Epilepsy

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • Cynthia Kerson, PhD

    Saybrook University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cynthia Kerson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Statistical analyzer
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor, Principal Investigator

Study Record Dates

First Submitted

March 25, 2026

First Posted

April 3, 2026

Study Start

August 11, 2025

Primary Completion (Estimated)

August 11, 2026

Study Completion (Estimated)

August 11, 2027

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations